Vecuronium Bromide
Product Images NDC 23360-160

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vecuronium Bromide (NDC 23360-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn - Strides Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Vecuronium Bromide Figure 01)

FDA Label Image

Image1 (Vecuronium Bromide Figure 02)

Image1 (Vecuronium Bromide Figure 02)
This is a warning label for Vecuronium Bromide injection which is a medication used for muscle relaxation during surgery. The medication should be used with caution as it may cause respiratory depression and facilities for artificial respiration must be immediately available. The medication should be reconstituted with bacteriostatic water for injection and should not be used in newborns as it contains benzyl alcohol. It should be used within 5 days of reconstitution and discard the unused portion within 24 hours. The medication should be protected from light and manufactured for Akorn-Strides LLC in India. Lot and expiry date details are also mentioned.*
FDA Label Image

Image4 (Vecuronium Bromide Figure 03)

Image4 (Vecuronium Bromide Figure 03)
This is a product information sheet for Vecuronium Bromide for Injection with NDC code 23360-160-10 for intravenous use only. Each 20 mL vial contains 1 mg of the active ingredient and other inactive ingredients like citric acid, mannitol, and sodium phosphate dibasic anhydrous. The product is for single use only, and the injection must be prepared immediately before use. The package insert provides information on the dosage, storage, and warnings related to the use of this medication, including the risks of respiratory depression. The product should be stored at 20°C to 25°C and protected from light. The carton contains ten molded vials with a size of 170 x 70 x 66mm. The product is manufactured by Akorn-Strides, LLC, in India.*
FDA Label Image

Image5 (Vecuronium Bromide Figure 04)

FDA Label Image

Image2 (Vecuronium Bromide Figure 05)

Image2 (Vecuronium Bromide Figure 05)
This appears to be a description of a lock bottom carton designed to hold 10 vials of a medication called Vecuronium Bromide for Injection. The carton has a size of 129 x 52 x 55mm and features a two-color design with a Pantone 1797 CV color and black. The carton also includes die-line drawings and a warning that the medication may cause respiratory depression. It should be stored at 20° to 25°C and protected from light until the time of use. If reconstituted, it should be used within 24 hours and is for single use only. The dosage information can be found in the package insert.*
FDA Label Image

Image3 (Vecuronium Bromide Figure 06)

Image3 (Vecuronium Bromide Figure 06)
Vecuronium Bromide for Injection is a medication for IV use only that is reconstituted to 1 mg/mL when mixed with 20 mL of sterile water or IV solutions. It is important to note that it may cause respiratory depression and artificial respiration facilities must be available. Dosage and storage information can be found in the package insert. The drug is manufactured by Akorn-Strides in India and contains benzyl alcohol, which should not be used on newborns. The LOT number, expiration date, and code number are also included.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.